Display options
Cite
Nandi S, Kumar M. Canine parvovirus: current perspective. Indian J Virol. 2010;21(1):31-44doi: 10.1007/s13337-010-0007-y.
Nandi, S., & Kumar, M. (2010). Canine parvovirus: current perspective. Indian journal of virology : an official organ of Indian Virological Society, 21(1), 31-44. https://doi.org/10.1007/s13337-010-0007-y
Nandi, S, and Kumar, Manoj. "Canine parvovirus: current perspective." Indian journal of virology : an official organ of Indian Virological Society vol. 21,1 (2010): 31-44. doi: https://doi.org/10.1007/s13337-010-0007-y
Nandi S, Kumar M. Canine parvovirus: current perspective. Indian J Virol. 2010 Jun;21(1):31-44. doi: 10.1007/s13337-010-0007-y. Epub 2010 Sep 03. PMID: 23637476; PMCID: PMC3550768.
Copy Download .nbib Format: NLM
Share it on

Indian J Virol. 2010 Jun;21(1):31-44. doi: 10.1007/s13337-010-0007-y. Epub 2010 Sep 03.

Canine parvovirus: current perspective.

Indian journal of virology : an official organ of Indian Virological Society

S Nandi, Manoj Kumar

Affiliations

  1. Virology Laboratory, Centre for Animal Disease Research and Diagnosis (CADRAD), Indian Veterinary Research Institute (IVRI), Izatnagar, 243122 UP India.

PMID: 23637476 PMCID: PMC3550768 DOI: 10.1007/s13337-010-0007-y

Abstract

Canine parvovirus 2 (CPV-2) has been considered to be an important pathogen of domestic and wild canids and has spread worldwide since its emergence in 1978. It has been reported from Asia, Australia, New Zealand, the Americas and Europe. Two distinct parvoviruses are now known to infect dogs-the pathogenic CPV-2 and CPV-1 or the minute virus of canine (MVC). CPV-2, the causative agent of acute hemorrhagic enteritis and myocarditis in dogs, is one of the most important pathogenic viruses with high morbidity (100%) and frequent mortality up to 10% in adult dogs and 91% in pups. The disease condition has been complicated further due to emergence of a number of variants namely CPV-2a, CPV-2b and CPV-2c over the years and involvement of domestic and wild canines. There are a number of different serological and molecular tests available for prompt, specific and accurate diagnosis of the disease. Further, both live attenuated and inactivated vaccines are available to control the disease in animals. Besides, new generation vaccines namely recombinant vaccine, peptide vaccine and DNA vaccine are in different stages of development and offer hope for better management of the disease in canines. However, new generation vaccines have not been issued license to be used in the field condition. Again, the presence of maternal antibodies often interferes with the active immunization with live attenuated vaccine and there always exists a window of susceptibility in spite of following proper immunization regimen. Lastly, judicious use of the vaccines in pet dogs, stray dogs and wild canids keeping in mind the new variants of the CPV-2 along with the proper sanitation and disinfection practices must be implemented for the successful control the disease.

Keywords: Canine parvovirus; Hemorrhagic enteritis; Minute virus of canine; Myocarditis; Vaccination

References

  1. Vet Pathol. 1980 May;17(3):282-93 - PubMed
  2. Vet Rec. 1996 May 18;138(20):495-6 - PubMed
  3. J Clin Microbiol. 1996 Sep;34(9):2101-5 - PubMed
  4. J Vet Med B Infect Dis Vet Public Health. 2005 Sep-Oct;52(7-8):316-9 - PubMed
  5. Clin Diagn Lab Immunol. 2005 Oct;12(10):1243-5 - PubMed
  6. Emerg Infect Dis. 2007 Aug;13(8):1222-4 - PubMed
  7. Vet Microbiol. 2006 Oct 5;117(1):75-9 - PubMed
  8. Vet Med Small Anim Clin. 1979 Jan;74(1):47-50 - PubMed
  9. Science. 1985 Nov 29;230(4729):1046-8 - PubMed
  10. J Vet Diagn Invest. 2008 Jul;20(4):488-91 - PubMed
  11. J Gen Virol. 2001 Dec;82(Pt 12):3021-3025 - PubMed
  12. Vet Rec. 1995 Jan 21;136(3):63-7 - PubMed
  13. J Virol. 2001 Apr;75(8):3896-902 - PubMed
  14. J Virol. 1992 May;66(5):2748-53 - PubMed
  15. J Vet Med B Infect Dis Vet Public Health. 2006 Dec;53(10):468-72 - PubMed
  16. Vet Rec. 2005 Sep 3;157(10):285-7 - PubMed
  17. J Vet Diagn Invest. 1999 Jul;11(4):365-7 - PubMed
  18. J Vet Diagn Invest. 1997 Jul;9(3):255-60 - PubMed
  19. J Am Vet Med Assoc. 1984 Sep 15;185(6):651-5 - PubMed
  20. Vet Microbiol. 1994 Jul;41(1-2):135-45 - PubMed
  21. Onderstepoort J Vet Res. 1998 Dec;65(4):239-42 - PubMed
  22. Vet Ther. 2008 Summer;9(2):94-101 - PubMed
  23. Am J Vet Res. 1980 Mar;41(3):410-4 - PubMed
  24. Virology. 1988 Oct;166(2):293-307 - PubMed
  25. J Virol. 1991 Dec;65(12):6544-52 - PubMed
  26. J Vet Diagn Invest. 2007 Sep;19(5):535-9 - PubMed
  27. J Clin Microbiol. 2004 Mar;42(3):1333-6 - PubMed
  28. J Virol Methods. 2006 Apr;133(1):92-9 - PubMed
  29. J Virol. 1992 Sep;66(9):5399-408 - PubMed
  30. Virology. 1996 Jan 15;215(2):186-9 - PubMed
  31. J Virol. 2002 Oct;76(20):10524-9 - PubMed
  32. Arch Virol. 2006 Sep;151(9):1881-7 - PubMed
  33. J Gen Virol. 2000 Feb;81(Pt 2):345-50 - PubMed
  34. Arch Virol. 2004 Nov;149(11):2261-9 - PubMed
  35. Vet Rec. 1995 Feb 18;136(7):174-5 - PubMed
  36. Arch Virol. 1979;61(1-2):1-11 - PubMed
  37. J Vet Diagn Invest. 2006 Jan;18(1):81-4 - PubMed
  38. J Vet Diagn Invest. 1996 Oct;8(4):427-32 - PubMed
  39. Am J Vet Res. 1980 May;41(5):784-91 - PubMed
  40. Res Vet Sci. 2010 Feb;88(1):169-71 - PubMed
  41. Vet Microbiol. 2007 Sep 20;124(1-2):147-52 - PubMed
  42. Vet Microbiol. 2006 Oct 5;117(1):9-13 - PubMed
  43. Zentralbl Veterinarmed B. 1980;27(1):11-21 - PubMed
  44. Vet Ital. 2010 Jan-Mar;46(1):69-81 - PubMed
  45. J Am Vet Med Assoc. 1980 Jun 1;176(11):1269-73 - PubMed
  46. J Clin Microbiol. 2002 Nov;40(11):3993-8 - PubMed
  47. Vet Med Small Anim Clin. 1980 Oct;75(10):1541-55 - PubMed
  48. Vet Microbiol. 2000 Jul 31;75(2):127-33 - PubMed
  49. Vet Microbiol. 2008 Apr 1;128(1-2):48-55 - PubMed
  50. J Clin Microbiol. 2007 Dec;45(12):4044-7 - PubMed
  51. J Virol. 1992 Dec;66(12):6858-67 - PubMed
  52. J Wildl Dis. 2001 Jul;37(3):594-607 - PubMed
  53. Baillieres Clin Haematol. 1995 Mar;8(1):57-71 - PubMed
  54. J Am Vet Med Assoc. 1979 Nov 1;175(9):897-900 - PubMed
  55. Clin Vaccine Immunol. 2008 Mar;15(3):534-9 - PubMed
  56. Schweiz Arch Tierheilkd. 2000 Mar;142(3):115-9 - PubMed
  57. Aust Vet J. 1979 Jan;55(1):36-7 - PubMed
  58. J Vet Med B Infect Dis Vet Public Health. 2000 May;47(4):273-6 - PubMed
  59. In Pract. 1981 May;3(3):5-14 - PubMed
  60. Cornell Vet. 1979 Apr;69(3):134-44 - PubMed
  61. Emerg Infect Dis. 2002 Apr;8(4):341-6 - PubMed
  62. Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):379-84 - PubMed
  63. Vet Rec. 1979 Aug 25;105(8):156-9 - PubMed
  64. J Virol. 1995 Nov;69(11):7274-7 - PubMed
  65. Vaccine. 2007 Jan 26;25(7):1161-6 - PubMed
  66. J Virol Methods. 1995 Nov;55(3):427-33 - PubMed
  67. J Gen Virol. 1982 Jul;61 (Pt l):33-41 - PubMed
  68. Can Vet J. 1979 May;20(5):126 - PubMed
  69. J Vet Diagn Invest. 1994 Apr;6(2):165-74 - PubMed
  70. J Virol. 1995 Aug;69(8):4702-10 - PubMed
  71. Zentralbl Veterinarmed B. 1996 Nov;43(9):545-54 - PubMed
  72. J Am Vet Med Assoc. 1996 Feb 15;208(4):542-6 - PubMed
  73. Vet Rec. 2003 May 10;152(19):588-91 - PubMed

Publication Types